Professor Farzin Farzaneh

King’s College London
Professor of Molecular Medicine, Director of Cell and Gene Therapy

Farzin Farzaneh D.Phil., FRCPath., FRSB
Professor of Molecular Medicine, and Director of Cell and Gene Therapy – King’s.
Consultant in Specialist Medicine, King’s College Hospital

Farzin Farzaneh holds the Chair of Molecular Medicine at King’s College London. He has published over 250 research articles with an average citation of over 30, and an Impact Factor of 47. He has run a licensed GMP facility at King’s College London, since 2001, for the production of cell and gene therapy based investigational medicinal products. Farzin has extensive industrial and academic collaborations, including research council, charitable and pharmaceutical sponsorships of over £25M. He is appointed by the Commission on Human Medicines, as a member of the Clinical Trials, Biologicals & Vaccines Expert Advisory Group since 2016. He is the recipient of 2016 Distinguished Scientist Award of the US Society for Experimental Biology & Medicine.

dont miss

Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

Cell and gene based therapy of cancer is making major improvements to the treatment of cancer. The development of new strategies for the development of chimeric antigen receptor T cells, genetically modified cancer cell vaccines and therapeutic cancer vaccines for the specific induction of cellular immunity will be described.

EVEN MORE SEMINARS

  • Dr Abeer Shabaan: Speaking at the Oncology Convention

    Dr Abeer Shabaan
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

  • Malcolm Wilson: Speaking at the Oncology Convention

    Malcolm Wilson
    The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

    Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

  • Dr Qamar Ghafoor: Speaking at the Oncology Convention

    Dr Qamar Ghafoor
    University Hospital Birmingham

    Stereotactive Radiotherapy Treatment for Primary Lung Cancers, and Oligometastasis to the Lungs.

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view

  • Dr Khurum Khan: Speaking at the Oncology Convention

    Dr Khurum Khan
    University College London Hospitals

    Translational research in GI Oncology- how to make progress?